Dr. Roland Achenjang, PharmD, MBA, a 2015 alumnus of Belmont’s MBA in Healthcare Management, is the founder and CEO of C2 Keep. C2Keep is Achenjang’s solution for a better and less painstaking way to manage a pharmacy’s Controlled Substances Inventory, primarily, Schedule II drugs.
To reduce the potential for diversion, the Controlled Substance Act (CSA) requires DEA registrants like pharmacies to maintain accurate and current counts of each schedule II drug bought, received, dispensed, disposed of or stolen from the pharmacy. Today, most independent retail and long-term care pharmacies keep track of this information manually in a logbook. This process is inefficient, time-consuming to manage, leads to errors and unnecessarily exposes pharmacies to DEA fines.
C2Keep replaces the logbook with a digital solution and includes additional safety features to make pharmacy employees’ lives easier. Features include barcode scanning; built-in calculators to improve transaction record accuracy; preventing the deletion of any transaction data to reduce drug diversion; and integration with pharmacy software and drug wholesalers to streamline the filling process.
Beta customers using the application have left great reviews. Cory Smith, owner and pharmacist at Knox Professional Pharmacy in Barbourville, KY said, “C2Keep saves a lot of additional steps and energy, scanning the stock bottle is great for accuracy, and the application ensures the math is correct. It is a win-win for everybody.”
C2Keep is scheduled for a full public rollout by the end of Q1 2022.
To learn more about the application, visit https://c2keep.com
